The challenge of viral reservoirs in HIV-1 infection

被引:486
作者
Blankson, JN [1 ]
Persaud, D
Siliciano, RF
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
来源
ANNUAL REVIEW OF MEDICINE | 2002年 / 53卷
关键词
AIDS; latency; HAART; sanctuary; persistence;
D O I
10.1146/annurev.med.53.082901.104024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A viral reservoir is a cell type or anaton-deal site in association with which a replication-competent form of the virus accumulates and persists with more stable kinetic properties than the main pool of actively replicating virus. This article reviews several cell types and anatomical sites proposed as potential reservoirs for HIV-1. It is now clear that HIV-1 persists in a small reservoir of latently infected resting memory CD4+ T cells, which shows minimal decay even in patients on highly active antiretroviral therapy (HAART). The persistence of virus in this reservoir is consistent with the biology of these cells and the long-term persistence of immunologic memory. The viral replication that continues in patients on suppressive HAART may also contribute to the stability of this reservoir. There may be other reservoirs, but the latent reservoir in resting CD4+ T cells appears to be sufficient to guarantee lifetime persistence of HIV-1 in the majority of patients on current HAART regimens, and unless new approaches are developed, eradication will not be possible. The clinical implications of this and other HIV-1 reservoirs are discussed.
引用
收藏
页码:557 / 593
页数:37
相关论文
共 207 条
  • [1] Immunological memory and protective immunity: Understanding their relation
    Ahmed, R
    Gray, D
    [J]. SCIENCE, 1996, 272 (5258) : 54 - 60
  • [2] ALHARTHI L, 2001, AIDS REV, V3, P4
  • [3] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [4] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease
    Autran, B
    Carcelain, G
    Li, TS
    Blanc, C
    Mathez, D
    Tubiana, R
    Katlama, C
    Debre, P
    Leibowitch, J
    [J]. SCIENCE, 1997, 277 (5322) : 112 - 116
  • [5] Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1-infected patients with and without AIDS dementia complex
    Aweeka, F
    Jayewardene, A
    Staprans, S
    Bellibas, SE
    Kearney, B
    Lizak, P
    Novakovic-Agopian, T
    Price, RW
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (01): : 39 - 43
  • [6] TEMPORAL TRENDS IN THE INCIDENCE OF HTV-1-RELATED NEUROLOGIC DISEASES - MULTICENTER AIDS COHORT STUDY, 1985-1992
    BACELLAR, H
    MUNOZ, A
    MILLER, EN
    COHEN, BA
    BESLEY, D
    SELNES, OA
    BECKER, JT
    MCARTHUR, JC
    [J]. NEUROLOGY, 1994, 44 (10) : 1892 - 1900
  • [7] In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline
    Blaak, H
    van't Wout, AB
    Brouwer, M
    Hooibrink, B
    Hovenkamp, E
    Schuitemaker, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) : 1269 - 1274
  • [8] Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection
    Blankson, JN
    Finzi, D
    Pierson, TC
    Sabundayo, BP
    Chadwick, K
    Margolick, JB
    Quinn, TC
    Siliciano, RF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) : 1636 - 1642
  • [9] HIGH-LEVEL RESISTANCE TO (-) ENANTIOMERIC 2'-DEOXY-3'-THIACYTIDINE IN-VITRO IS DUE TO ONE AMINO-ACID SUBSTITUTION IN THE CATALYTIC SITE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    BOUCHER, CAB
    CAMMACK, N
    SCHIPPER, P
    SCHUURMAN, R
    ROUSE, P
    WAINBERG, MA
    CAMERON, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) : 2231 - 2234
  • [10] BREW BJ, 1998, WORLDS AIDS C 12 GEN